Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab thrombolytic therapy. Results of the thrombolysis and angioplasty in mycardial infaraction (TAMI) 8 pilot study Academic Article Article uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Coronary Artery Disease
  • Drug-Eluting Stents
  • Heart Transplantation

abstract

  • Profound inhibition of platelet aggregation after thrombolysis was associated with bleeding rates comparable to those in control patients and a low rate of recurrent ischemia. The combination of m7E3 Fab and rt-PA, heparin and aspirin appears to be a promising and safe combination that should be evaluated in further studies of patients with acute myocardial infarction.

publication date

  • January 1993

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/0735-1097(93)90041-X

PubMed ID

  • 8335808

Additional Document Info

start page

  • 381

end page

  • 9

volume

  • 22

number

  • 2